PL2616065T3 - GLIKO-PODSTAWIONE DIHYDROKSYCHLORYNY I ß-FUNKCJONALIZOWANE CHLORYNY DO PRZECIWDROBNOUSTROJOWEJ TERAPII FOTODYNAMICZNEJ - Google Patents
GLIKO-PODSTAWIONE DIHYDROKSYCHLORYNY I ß-FUNKCJONALIZOWANE CHLORYNY DO PRZECIWDROBNOUSTROJOWEJ TERAPII FOTODYNAMICZNEJInfo
- Publication number
- PL2616065T3 PL2616065T3 PL11869827T PL11869827T PL2616065T3 PL 2616065 T3 PL2616065 T3 PL 2616065T3 PL 11869827 T PL11869827 T PL 11869827T PL 11869827 T PL11869827 T PL 11869827T PL 2616065 T3 PL2616065 T3 PL 2616065T3
- Authority
- PL
- Poland
- Prior art keywords
- chlorins
- glyco
- functionalized
- photodynamic therapy
- substituted dihydroxy
- Prior art date
Links
- 230000000845 anti-microbial effect Effects 0.000 title 1
- 239000004599 antimicrobial Substances 0.000 title 1
- 150000004035 chlorins Chemical class 0.000 title 1
- 238000002428 photodynamic therapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36671810P | 2010-07-22 | 2010-07-22 | |
| PCT/US2011/045063 WO2013015774A1 (en) | 2011-07-22 | 2011-07-22 | Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy |
| EP11869827.3A EP2616065B1 (en) | 2010-07-22 | 2011-07-22 | Glyco-substituted dihydroxy-chlorins and b-functionalized chlorins for anti-microbial photodynamic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2616065T3 true PL2616065T3 (pl) | 2018-05-30 |
Family
ID=47006517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11869827T PL2616065T3 (pl) | 2010-07-22 | 2011-07-22 | GLIKO-PODSTAWIONE DIHYDROKSYCHLORYNY I ß-FUNKCJONALIZOWANE CHLORYNY DO PRZECIWDROBNOUSTROJOWEJ TERAPII FOTODYNAMICZNEJ |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9308185B2 (pl) |
| EP (1) | EP2616065B1 (pl) |
| CN (1) | CN103096887B (pl) |
| BR (1) | BR112013001577B1 (pl) |
| IL (1) | IL224380A (pl) |
| MX (1) | MX352281B (pl) |
| PL (1) | PL2616065T3 (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6041360B2 (ja) * | 2011-07-22 | 2016-12-07 | バイオリテック ウンターネーメンスベタイリグンクス ツヴァイ アクツィエンゲゼルシャフト | 抗菌性光線力学療法のための、糖−置換ジヒドロキシ−クロリン及びβ−官能化クロリン |
| US9156849B2 (en) * | 2011-08-12 | 2015-10-13 | Biolitec Pharma Marketing Ltd | Application of β-functionalized dihydroxy-chlorins for PDT |
| CN103285403B (zh) * | 2013-06-21 | 2015-03-04 | 苏州大学 | 一种络合卟啉含糖光敏剂及其制备方法 |
| WO2016051361A1 (en) | 2014-09-30 | 2016-04-07 | Biolitec Unternehmensbeteiligungs Ii Ag | Specifically meso-substituted porphyrins and chlorins for photodynamic therapy |
| US12109429B2 (en) | 2015-07-28 | 2024-10-08 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
| WO2017019836A1 (en) | 2015-07-28 | 2017-02-02 | Photonmd, Llc | Systems and methods for phototherapeutic modulation of nitric oxide |
| EP3210626A1 (en) | 2016-02-26 | 2017-08-30 | biolitec Unternehmensbeteiligungs II AG | Conjugates of porphyrinoid photosensitizers and glycerol-based polymers for photodynamic therapy |
| WO2020120474A1 (en) | 2018-12-10 | 2020-06-18 | Universität Hamburg | Specifically glyco-substituted porphyrins and chlorins for photodynamic therapy |
| US12011611B2 (en) | 2020-03-19 | 2024-06-18 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US11986666B2 (en) | 2020-03-19 | 2024-05-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US12115384B2 (en) | 2021-03-15 | 2024-10-15 | Know Bio, Llc | Devices and methods for illuminating tissue to induce biological effects |
| US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3005025A (en) * | 1959-08-07 | 1961-10-17 | American Cyanamid Co | Preparation of neutral chlortetracycline |
| FR2709491B1 (fr) * | 1993-09-03 | 1995-10-27 | Centre Nat Rech Scient | Nouveaux dérivés de porphyrines et leurs applications notamment en thérapeutique. |
| EP1279676A1 (en) * | 2001-07-19 | 2003-01-29 | Institut Curie | Porphyrin derivatives for photodynamic therapy |
| US7110533B2 (en) * | 2004-05-18 | 2006-09-19 | Time Warner Cable, Inc. | Telephone NID isolation module |
| EP2350058B1 (en) * | 2008-09-18 | 2018-10-24 | biolitec Unternehmensbeteiligungs II AG | Novel method and application of unsymmetrically meso-substituted porphyrins and chlorins for pdt |
| EP2870159B1 (en) * | 2010-07-22 | 2017-06-28 | biolitec Unternehmensbeteiligungs II AG | APPLICATION OF ß-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT |
-
2011
- 2011-07-22 BR BR112013001577-2A patent/BR112013001577B1/pt not_active IP Right Cessation
- 2011-07-22 CN CN201180038608.8A patent/CN103096887B/zh not_active Expired - Fee Related
- 2011-07-22 EP EP11869827.3A patent/EP2616065B1/en active Active
- 2011-07-22 PL PL11869827T patent/PL2616065T3/pl unknown
- 2011-07-22 MX MX2013000876A patent/MX352281B/es active IP Right Grant
- 2011-07-22 US US13/189,113 patent/US9308185B2/en active Active
-
2013
- 2013-01-23 IL IL224380A patent/IL224380A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2616065A4 (en) | 2014-05-14 |
| US9308185B2 (en) | 2016-04-12 |
| MX2013000876A (es) | 2013-04-30 |
| EP2616065B1 (en) | 2017-11-01 |
| EP2616065A1 (en) | 2013-07-24 |
| BR112013001577B1 (pt) | 2021-05-04 |
| US20120263625A1 (en) | 2012-10-18 |
| CN103096887B (zh) | 2017-12-29 |
| MX352281B (es) | 2017-11-16 |
| CN103096887A (zh) | 2013-05-08 |
| BR112013001577A2 (pt) | 2017-12-12 |
| IL224380A (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2616065T3 (pl) | GLIKO-PODSTAWIONE DIHYDROKSYCHLORYNY I ß-FUNKCJONALIZOWANE CHLORYNY DO PRZECIWDROBNOUSTROJOWEJ TERAPII FOTODYNAMICZNEJ | |
| IL222481A0 (en) | Combination therapy | |
| ZA201207574B (en) | Phytocannabinoids in the treatment of cancer | |
| EP2552323A4 (en) | COMBINATION THERAPY | |
| GB0900461D0 (en) | Photodynamic therapy device | |
| PL2440287T3 (pl) | Urządzenie do terapii fotodynamicznej | |
| PL2652193T3 (pl) | Obróbka | |
| IL222702A0 (en) | Incontinence treatment | |
| EP2827818A4 (en) | LASER FOR PHOTODYNAMIC THERAPY | |
| GB2496805B (en) | Compounds for photodynamic therapy | |
| EP2537530A4 (en) | RADIOTHERAPY AGENT | |
| IL222958A0 (en) | Cancer treatment | |
| HK1207013A1 (en) | Catheter for photodynamic therapy | |
| GB201011411D0 (en) | Therapeutic compounds and their use | |
| EP2585115A4 (en) | ANTICANCER TREATMENT | |
| WO2011130486A9 (en) | Combination treatments and formulations for cancer | |
| PT2619331T (pt) | Métodos de tratamento de cancro incluindo rastreio de nqo1 | |
| GB201013573D0 (en) | Treatment | |
| GB201005394D0 (en) | Therapy | |
| GB201718726D0 (en) | Phytocannabinoids in the treatment of cancer | |
| PL2528658T3 (pl) | Urządzenie do zastosowania w przeciwbakteryjnej fototerapii dynamicznej | |
| EP2629766A4 (en) | COMBINATION THERAPY | |
| GB201014097D0 (en) | Treatment | |
| GB201109133D0 (en) | Photodynamic therapy | |
| GB201014917D0 (en) | Therapeutic treatments |